Ayush export declines by 7.4% in first nine months of FY 26

New Delhi:  Exports of Ayush and herbal products have reported a decline of 7.42% during the first nine months of the fiscal year 2025-26, compared to the same period of previous fiscal year.

Exports during the quarter from October to December, 2025 registered a decline of 16.14%, while for the month of December, the exports declined almost 10.2%, on a Year-over-Year (YoY) basis.

During the period of April to December, 2025, exports of Ayush and herbal products stood at $471.67 million compared to $509.49 million during the corresponding period of previous fiscal year. Quantity of exports declined 1.29% to 91,493 MT during the period compared to 92,685 MT a year ago.

During the third quarter of the fiscal year, ending December 31, 2025, exports stood at $137.66 million, as against $164.15 million during the same period a year ago. Quantity witnessed a decline of almost 6% to 29,653 MT compared to 31,502 MT registered in the same quarter a year ago.

Exports during the month of December, 2025, was at $52.15 million, as compared to $58.05 million in the same month of previous fiscal year. Quantity declined 1.5% to 12,315 MT, as against 12,133.6 MT reported during December, 2024.

In Rupee terms, exports of Ayush and herbal products declined 3.78% at Rs. 4,111.5 crore during the first nine months of the fiscal year, compared to Rs. 4,272.93 crore during the same period of last year. Exports during the quarter ended December reported a 11.45% decline at Rs. 1,227.6 crore on a YoY basis as against Rs. 1,386.4 crore last year.

During the month of December, exports declined 4.8% in rupee terms, at Rs. 469.8 crore as against Rs. 493.38 crore during the same month of last year.

As reported earlier, the exports of Ayush and herbal products have reported a decline of 3.3% during the first half of the fiscal year 2025-26, at $334.01 million compared to $345.33 million during the corresponding period of previous fiscal year. Quantity of exports, however, grew 1.13% to 61,879 MT during the period.

Exports during the first quarter of the current fiscal, ended June 30, 2025 reported a marginal growth of 6% and stood at $175.7 million, as against $174.8 million during the three months from April to June, 2024.

Ayush and herbal products exports reported a growth of 3.6 per cent during the fiscal year 2023-24, at $651.17 million as compared to the same period of previous year. During 2022-23, the exports were $628.54 million. The year 2022-23 registered a growth of 2.68 per cent in exports, from $612.12 million in the previous year.

The Ministry of Ayush has established Ayush Export Promotion Council (Ayushexcil) to promote Ayush products and services globally by the Ministry of Ayush and supported by the Union ministry of commerce. It was officially launched at Global Ayush Investment and Innovation Summit held in Gandhinagar, Gujarat on April 20, 2022, and aimed to oversee exports of products of Ayurveda, Homoeopathy, Siddha, Sowa/Rigpa and Unani systems and address trade issues pertaining to these sectors.

Related Posts

Pvt nursing home sealed in Chatra after woman, unborn baby die

Chatra: The Chatra administration on Sunday sealed a private nursing home operating near Chatra bus stand following the death of a 20-year-old pregnant woman and her unborn child. The deceased…

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Thirty doctors who were found guilty of accepting a foreign trip worth Rs 2 crore to Paris and Monaco, funded by a pharma company, come from at least nine states.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Drug companies directed to step up vigil on adverse reactions

Drug companies directed to step up vigil on adverse reactions

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities

AI-designed universal coronavirus vaccine passes first human trial

AI-designed universal coronavirus vaccine passes first human trial